MAGNETIC-RESONANCE-IMAGING OF THE WRIST IN DEFINING REMISSION OF RHEUMATOID-ARTHRITIS

Citation
J. Lee et al., MAGNETIC-RESONANCE-IMAGING OF THE WRIST IN DEFINING REMISSION OF RHEUMATOID-ARTHRITIS, Journal of rheumatology, 24(7), 1997, pp. 1303-1308
Citations number
18
Categorie Soggetti
Rheumatology
Journal title
ISSN journal
0315162X
Volume
24
Issue
7
Year of publication
1997
Pages
1303 - 1308
Database
ISI
SICI code
0315-162X(1997)24:7<1303:MOTWID>2.0.ZU;2-A
Abstract
Objective. To assess the efficacy of magnetic resonance imaging (MRI) in objectively defining a state of remission in rheumatoid arthritis ( RA) after treatment. Methods. Ten patients with RA involving the wrist were evaluated before treatment with methotrexate and hydroxychloroqu ine, and then mean 14 mo later with a followup evaluation. Clinical va riables, laboratory measurements, and MRI using various techniques (TI weighted image, T2 weighted image, fat suppression T2 weighted image, postcontrast T1 weighted image, postcontrast dynamic image, postcontr ast 3 dimensional image) were observed. Remission was defined by ACR c rite ria. MRI changes were observed using 3 variables: extent of synov ial proliferation; extent of bone marrow edema; and development of new erosion. In 6 of 10 patients, synovial signal intensity time curve ch anges at 30 s (E-30 ratio) were determined for quantitative assessment of synovitis. Results. Four patients achieved remission and 6 did not . All patients in remission showed decrease in extent of synovial prol iferation and bone marrow edema with no newly developed erosion after treatment, compared to baseline. Five of 6 patients in nonremission sh owed newly developed erosions with variable changes in extent of synov ial proliferation and bone marrow edema. E-30 ratio was determined in 3 patients in the remission group and 3 in the nonremission group, wit h 48% reduction in the former compared to 9% reduction in the latter. Conclusion. MRI is feasible for objectively defining remission and ass essing the therapeutic effect of antirheumatic drugs; utility of MRI m easures in clinical remission criteria remains to be verified.